We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

81 hedge funds and large institutions have $61.5M invested in HilleVax in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

7% more funds holding

Funds holding: 7681 (+5)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1.92% less ownership

Funds ownership: 86%84.08% (-1.9%)

31% less capital invested

Capital invested by funds: $88.7M → $61.5M (-$27.2M)

33% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 30

Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
11
Increased
20
Reduced
30
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$15.4M
TPC
2
Takeda Pharmaceutical Company
Japan
$9.75M
TCM
3
Tang Capital Management
California
$7.13M
LMC
4
Lightspeed Management Company
California
$3.34M -$69.3K -37,505 -2%
BlackRock
5
BlackRock
New York
$3.04M -$125K -67,775 -3%
Franklin Resources
6
Franklin Resources
California
$2.84M
DM
7
Deerfield Management
New York
$2.73M
CG
8
Carlyle Group
District of Columbia
$2.65M
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.3M -$37.9K -20,505 -1%
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$1.45M +$55 +30 +0%
SG
11
StepStone Group
California
$1.2M
Goldman Sachs
12
Goldman Sachs
New York
$951K -$80.7K -43,638 -6%
Morgan Stanley
13
Morgan Stanley
New York
$951K -$58.6K -31,702 -5%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$883K +$9.21K +4,981 +0.8%
State Street
15
State Street
Massachusetts
$870K -$14.3K -7,740 -1%
SB
16
Samsara BioCapital
California
$579K
TC
17
Trium Capital
United Kingdom
$548K +$699K +378,205 New
QUSVM
18
Qiming U.S. Ventures Management
Washington
$540K
Deutsche Bank
19
Deutsche Bank
Germany
$471K -$178K -96,066 -23%
LA
20
Legacy Advisors
Pennsylvania
$348K +$190 +103 New
SCM
21
Stonepine Capital Management
Oregon
$346K +$197K +106,603 +81%
Northern Trust
22
Northern Trust
Illinois
$328K -$42.7K -23,081 -9%
Bank of America
23
Bank of America
North Carolina
$268K -$87.4K -47,269 -20%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$240K -$452K -244,487 -60%
Millennium Management
25
Millennium Management
New York
$224K -$475K -257,036 -62%

HLVX Hedge Fund Activity: Q1 2025 in Review

81 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2025, worth a combined $61.5M — down 31% from $88.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HLVX positions and 6 closed out — a net gain of 5 holders — while 20 added to existing stakes and 30 trimmed.

The largest buyer was Trium Capital, opening a new position worth an estimated $699K. The largest seller was Millennium Management, cutting an estimated $475K.

  • 81 institutional investors held HilleVax (HLVX) as of Q1 2025, up from 76 in Q4 2024.
  • Funds reported $61.5M of HilleVax stock for Q1 2025, down 31% quarter-over-quarter.
  • 11 funds opened new HilleVax positions in Q1 2025 and 6 closed out, a net change of +5 holders.
  • The largest HilleVax buyer in Q1 2025 was Trium Capital, an estimated $699K added.
  • The largest HilleVax seller in Q1 2025 was Millennium Management, an estimated $475K sold.

Based on aggregated 13F filings for Q1 2025.